1. Home
  2. TLPH vs ADGM Comparison

TLPH vs ADGM Comparison

Compare TLPH & ADGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLPH
  • ADGM
  • Stock Information
  • Founded
  • TLPH 2005
  • ADGM 2011
  • Country
  • TLPH United States
  • ADGM United States
  • Employees
  • TLPH N/A
  • ADGM N/A
  • Industry
  • TLPH Biotechnology: Pharmaceutical Preparations
  • ADGM
  • Sector
  • TLPH Health Care
  • ADGM
  • Exchange
  • TLPH Nasdaq
  • ADGM NYSE
  • Market Cap
  • TLPH 12.7M
  • ADGM 12.7M
  • IPO Year
  • TLPH 2011
  • ADGM N/A
  • Fundamental
  • Price
  • TLPH $0.63
  • ADGM $1.17
  • Analyst Decision
  • TLPH Strong Buy
  • ADGM
  • Analyst Count
  • TLPH 2
  • ADGM 0
  • Target Price
  • TLPH $4.50
  • ADGM N/A
  • AVG Volume (30 Days)
  • TLPH 101.8K
  • ADGM 321.0K
  • Earning Date
  • TLPH 03-05-2025
  • ADGM 02-15-2025
  • Dividend Yield
  • TLPH N/A
  • ADGM N/A
  • EPS Growth
  • TLPH N/A
  • ADGM N/A
  • EPS
  • TLPH N/A
  • ADGM N/A
  • Revenue
  • TLPH $281,000.00
  • ADGM $543,000.00
  • Revenue This Year
  • TLPH N/A
  • ADGM N/A
  • Revenue Next Year
  • TLPH N/A
  • ADGM N/A
  • P/E Ratio
  • TLPH N/A
  • ADGM N/A
  • Revenue Growth
  • TLPH N/A
  • ADGM 187.30
  • 52 Week Low
  • TLPH $0.50
  • ADGM $0.75
  • 52 Week High
  • TLPH $1.61
  • ADGM $9.34
  • Technical
  • Relative Strength Index (RSI)
  • TLPH 46.28
  • ADGM N/A
  • Support Level
  • TLPH $0.54
  • ADGM N/A
  • Resistance Level
  • TLPH $0.73
  • ADGM N/A
  • Average True Range (ATR)
  • TLPH 0.07
  • ADGM 0.00
  • MACD
  • TLPH -0.00
  • ADGM 0.00
  • Stochastic Oscillator
  • TLPH 31.46
  • ADGM 0.00

About TLPH Talphera Inc.

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

About ADGM ADAGIO MEDICAL HOLDINGS INC

Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.

Share on Social Networks: